While direct evidence for role of anti-Survivin antibodies in inducing therapeutic response is lacking, it is possible that induction of anti-Survivin antibodies after antigen immunization may block the overexpression of Survivin on cancer cells or inhibit Survivin expressed on exosomes. This evidence concerns the gene BIRC5 and cancer.